These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24479608)

  • 1. Early caffeine therapy for prevention of bronchopulmonary dysplasia in preterm infants.
    Taha D; Kirkby S; Nawab U; Dysart KC; Genen L; Greenspan JS; Aghai ZH
    J Matern Fetal Neonatal Med; 2014 Nov; 27(16):1698-702. PubMed ID: 24479608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early versus Late Caffeine Therapy Administration in Preterm Neonates: An Updated Systematic Review and Meta-Analysis.
    Karlinski Vizentin V; Madeira de Sá Pacheco I; Fahel Vilas Bôas Azevêdo T; Florêncio de Mesquita C; Alvim Pereira R
    Neonatology; 2024; 121(1):7-16. PubMed ID: 37989113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preventive effect of caffeine on bronchopulmonary dysplasia in preterm infants].
    Liu Y; Dong WB
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 Jul; 20(7):598-602. PubMed ID: 30022766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeine for apnea and prevention of neurodevelopmental impairment in preterm infants: systematic review and meta-analysis.
    Oliphant EA; Hanning SM; McKinlay CJD; Alsweiler JM
    J Perinatol; 2024 Jun; 44(6):785-801. PubMed ID: 38553606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors for poor daily weight gain in preterm neonates exposed to different dose regimens of caffeine in ICU- a retrospective cohort study.
    Ahmed S; Rehman AU; Bibi Z; Iftikhar S; Raza M; Yousuf HMA; Naz F; Shah SAM; Mir SL; Bibi A; Khan WA; Salat MS; Ambreen G; Hussain K
    BMC Pediatr; 2024 Jun; 24(1):401. PubMed ID: 38898410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration time of caffeine in preterm infants: systematic review and meta-analysis.
    Trindade GS; Procianoy RS; Dos Santos VB; Dornelles AD; Silveira RC
    J Perinatol; 2024 Jul; ():. PubMed ID: 38956314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EBNEO Commentary: Does the effect of hydrocortisone in preterm infants depend on the baseline risk of BPD?
    Nelin TD; Bamat NA
    Acta Paediatr; 2023 Dec; 112(12):2620-2621. PubMed ID: 37740525
    [No Abstract]   [Full Text] [Related]  

  • 8. Caffeine therapy in preterm infants: effects in 2nd and 3rd childhood.
    Lopes JM; Almeida NRM; Andrade AS; Prado VA
    Rev Paul Pediatr; 2024; 43():e2024036. PubMed ID: 38985052
    [No Abstract]   [Full Text] [Related]  

  • 9. Caffeine and neonatal acute kidney injury.
    Yang K; Liu J; He T; Dong W
    Pediatr Nephrol; 2024 May; 39(5):1355-1367. PubMed ID: 37665410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine: how early is too early?
    Kilpatrick R; Davis JM; Aranda JV
    Pediatr Res; 2024 Apr; ():. PubMed ID: 38643263
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of early caffeine administration and neonatal outcomes in very preterm neonates.
    Lodha A; Seshia M; McMillan DD; Barrington K; Yang J; Lee SK; Shah PS;
    JAMA Pediatr; 2015 Jan; 169(1):33-8. PubMed ID: 25402629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review and meta-analysis of clinical outcomes of early caffeine therapy in preterm neonates.
    Kua KP; Lee SW
    Br J Clin Pharmacol; 2017 Jan; 83(1):180-191. PubMed ID: 27526255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Pilot Randomized Controlled Trial of Early versus Routine Caffeine in Extremely Premature Infants.
    Katheria AC; Sauberan JB; Akotia D; Rich W; Durham J; Finer NN
    Am J Perinatol; 2015 Jul; 32(9):879-86. PubMed ID: 25607226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001146. PubMed ID: 29063585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Flow Nasal Cannula Use Is Associated with Increased Morbidity and Length of Hospitalization in Extremely Low Birth Weight Infants.
    Taha DK; Kornhauser M; Greenspan JS; Dysart KC; Aghai ZH
    J Pediatr; 2016 Jun; 173():50-55.e1. PubMed ID: 27004673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of caffeine therapy in very low birth weight infants.
    Schmidt B; Davis PG; Roberts RS
    J Pediatr; 2014 May; 164(5):957-8. PubMed ID: 24630349
    [No Abstract]   [Full Text] [Related]  

  • 17. Bronchopulmonary dysplasia: clinical perspective.
    Jain D; Bancalari E
    Birth Defects Res A Clin Mol Teratol; 2014 Mar; 100(3):134-44. PubMed ID: 24578124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Caffeine Use in Very Low Birth Weight Infants and Neonatal Outcomes: A Systematic Review and Meta-Analysis.
    Park HW; Lim G; Chung SH; Chung S; Kim KS; Kim SN
    J Korean Med Sci; 2015 Dec; 30(12):1828-35. PubMed ID: 26713059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shifting the boundaries for early caffeine initiation in neonatal practice: Results of a prospective, multicenter study on very preterm infants with respiratory distress syndrome.
    Borszewska-Kornacka MK; Hożejowski R; Rutkowska M; Lauterbach R
    PLoS One; 2017; 12(12):e0189152. PubMed ID: 29261723
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.